NVD Insider Trading Activity and SEC Form 4 Filings
NVD insider trading summary
No open-market insider purchases or sales of Novadel Pharma Inc (NVD) have been reported on SEC Form 4 in the past 12 months.
Latest NVD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 11, 2009 | Steven B Ratoff | Chief Executive Officer | Buy | $4K (26,200 @ $0.15) |
| Dec 11, 2009 | Steven B Ratoff | Chief Executive Officer | Buy | $82K (465,800 @ $0.18) |
| Dec 11, 2009 | Steven B Ratoff | Chief Executive Officer | Buy | $1K (8,000 @ $0.13) |
| Dec 8, 2009 | Steven B Ratoff | Chief Executive Officer | Buy | $37K (263,866 @ $0.14) |
| Dec 8, 2009 | Steven B Ratoff | Chief Executive Officer | Buy | $35K (236,134 @ $0.15) |
| Aug 30, 2007 | Thomas E Bonney | Director | Buy | $4K (5,300 @ $0.79) |
| Aug 30, 2007 | William F Phd Hamilton | Director | Buy | $3K (4,000 @ $0.80) |
| Aug 29, 2007 | Mark J Baric | Director | Buy | $4K (4,900 @ $0.80) |
| Aug 28, 2007 | Mark J Baric | Director | Buy | $69 (100 @ $0.69) |
| Aug 28, 2007 | Steven B Ratoff | Director | Buy | $3K (3,600 @ $0.73) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.